We describe 2 patients with NSCLC harboring <i>EGFR</i> fusion mutations (<i>EGFR-MACF1</i> and <i>EGFR-GNAT3</i>) combined with <i>EGFR</i> amplification. This evidence concerns the gene GNAT3 and non-small cell lung carcinoma.